XML 78 R64.htm IDEA: XBRL DOCUMENT v3.6.0.2
Reportable Segment Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Jul. 31, 2016
Product revenue:          
Product Revenue $ 130,330 $ 125,938 $ 250,582 $ 240,067  
Engineering revenue:          
Engineering Revenue 1,204 1,931 2,077 2,750  
Net revenue:          
Total net revenue 131,534 127,869 252,659 242,817  
Income from operations:          
Income (loss) from operations 9,450 1,509 13,408 3,497  
Total other income (loss), net 30 (3,500) (400) (4,000)  
Income (loss) before income taxes 9,478 (1,998) 12,994 (468)  
Identifiable total assets by segment:          
Assets 628,443   628,443   $ 632,897
Asset impairment charges 10,423   10,423    
Total Identifiable Assets          
Identifiable total assets by segment:          
Assets 564,300 559,000 564,300 559,000  
Reportable segments          
Identifiable total assets by segment:          
Assets 365,400 393,400 365,400 393,400  
Corporate          
Identifiable total assets by segment:          
Identifiable assets (excluding goodwill) [1] 198,900 165,600 198,900 165,600  
Medical Imaging          
Product revenue:          
Product Revenue 71,200 72,400 137,700 136,800  
Engineering revenue:          
Engineering Revenue 1,200 1,100 1,900 1,700  
Net revenue:          
Total net revenue 72,400 73,500 139,600 138,500  
Income from operations:          
Income (loss) from operations [2] 12,200 11,600 18,900 18,000  
Medical Imaging | Reportable segments          
Identifiable total assets by segment:          
Assets 179,900 191,100 179,900 191,100  
Ultrasound          
Product revenue:          
Product Revenue 40,300 42,600 75,900 79,100  
Engineering revenue:          
Engineering Revenue   700 200 900  
Net revenue:          
Total net revenue 40,300 43,300 76,100 80,000  
Income from operations:          
Income (loss) from operations [3] (4,500) (9,900) (10,300) (14,500)  
Ultrasound | Reportable segments          
Identifiable total assets by segment:          
Assets 142,200 152,500 142,200 152,500  
Security and Detection          
Product revenue:          
Product Revenue 18,800 10,900 37,000 24,200  
Engineering revenue:          
Engineering Revenue   200   200  
Net revenue:          
Total net revenue 18,800 11,100 37,000 24,400  
Income from operations:          
Income (loss) from operations [4] 1,800 (200) 4,800    
Security and Detection | Reportable segments          
Identifiable total assets by segment:          
Assets 43,300 $ 49,800 43,300 $ 49,800  
Pathfinder Therapeutics Inc          
Identifiable total assets by segment:          
Asset impairment charges $ 600   $ 600    
[1] Includes cash and cash equivalents of $139.9 million and $97.3 million as of January 31, 2017 and July 31, 2016, respectively.
[2] Includes restructuring charges of $0.09 million and $1.9 million for three months ended January 31, 2017 and January 31, 2016, respectively and $0.11 million and $4.0 million for six months January 31, 2017 and January 31, 2016.
[3] Includes restructuring charges of $0.17 million and $0.6 million for three months ended January 31, 2017 and January 31, 2016, respectively and $0.18 million and $1.3 million for six months January 31, 2017 and January 31, 2016. Includes contingent consideration charges of $(8.2) million and $(8.1) million related to Oncura for three and six months ended January 31, 2017, respectively, asset impairment charges of $9.8 million related to Oncura for three and six months ended January 31, 2017, charges for the BK Medical matter of $10.1 million for three and six months ended January 31, 2016.
[4] Includes restructuring charges of $0.01 million and $0.6 million for three months ended January 31, 2017 and January 31, 2016, respectively and $0.01 million and $1.2 million for six months January 31, 2017 and January 31, 2016. Includes asset impairment charges of $0.6 million related to Pathfinder for three and six months ended January 31, 2017.